Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Intuitive Surgical Stock Just Fell Despite a 22% Revenue Jump. Here's What Investors Are Missing.

Selling surgical robots is not the largest source of Intuitive Surgical's revenue.

Intuitive Surgical's stock price declined following the company's earnings report on October 20, despite a 22% increase in revenue. This seemingly contradictory trend arises from the fact that surgical robot sales are not the primary driver of the company's revenue. The main concern for investors is the growing competition in the surgical robotics market.

Medtronic and Johnson & Johnson, both reputable medical device manufacturers, have entered this space. Consequently, investors perceive this increasing competition as a significant threat to Intuitive Surgical's growth prospects.

However, despite the emergence of new competitors, Intuitive Surgical has continued to grow. In the third quarter of 2026, the company sold more da Vinci systems than it did in the same quarter of 2025. Additionally, the number of procedures utilizing a da Vinci system rose by 15%, whereas the number of installed systems increased by only 12% year-over-year.

This indicates a higher demand for robotic surgery and highlights the company's largest strength: the sale of instruments, accessories, and services, which constitute the majority of Intuitive Surgical's revenue.

While Intuitive Surgical's stock price has rebounded from the earnings-related drop, the initial decline underscores a perception issue. Although new competition poses a business challenge, the company's extensive installed base of over 12,000 systems has generated a recurring cash flow machine. Moreover, even though surgical robotics is a well-established healthcare solution, it is not yet saturated, and there is significant room for growth worldwide.

In conclusion, investors should remember two crucial points about Intuitive Surgical. First, the company has a robust foundation of recurring income from parts and services sales, which will likely continue to grow despite the increased competition. Second, the surgical robotics market is still in its early stages, providing ample opportunities for expansion.

Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Also reported by 1 other outlet

Read the original at fool.com →

More in Finance & Markets

More from Sunday 1 November →